Efficacy and safety of pemetrexed maintenance chemotherapy for advanced non-small cell lung cancer in a real-world setting

CONCLUSIONS: Pemetrexed maintenance chemotherapy can improve PFS in patients with advanced nonsquamous NSCLC with good tolerability.PMID:33841970 | PMC:PMC8024837 | DOI:10.21037/jtd-21-337
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Authors: Source Type: research